Thomas Advanced Medical Revenue and Competitors
Estimated Revenue & Valuation
- Thomas Advanced Medical's estimated annual revenue is currently $775k per year.
- Thomas Advanced Medical's estimated revenue per employee is $155,000
Employee Data
- Thomas Advanced Medical has 5 Employees.
- Thomas Advanced Medical grew their employee count by 0% last year.
Thomas Advanced Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Account Development | Reveal Email/Phone |
Thomas Advanced Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Thomas Advanced Medical?
Thomas Advanced Medical was founded by a dedicated group of physicians and researchers focused on delivering safe and effective biological therapeutics. With years of experience in the fields of clinical regenerative medicine and biotechnology, Thomas was envisioned by clinical researchers for the benefit of the medical community at large. Thomas Advanced Medical is an active sponsor of multiple current clinical trials in the USA. These landmark studies investigate a broad set of disease conditions including a timely investigation for the treatment of COVID-19 through the use of stem cell derived therapies. Through sound scientific theory coupled with clinical research, our stem cell derived biological products help patients for the treatment of many diseases including cardiac diseases, vascular disorders, dementia, Alzheimer’s, Parkinson’s, lung diseases, orthopedic conditions, diabetes, and pain management. Thomas Advanced Medical delivers clinical-grade allogeneicaly derived stem cell therapeutics—products that adhere to US FDA regulations through US FDA regulated facilities. Thomas is committed to ensuring products which are safe and effective for innovative tissue repair and rejuvenation therapy.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.3M | 5 | -17% | N/A |
#2 | $0.1M | 5 | -58% | $535M |
#3 | $0.4M | 5 | -44% | N/A |
#4 | $0.4M | 5 | -17% | N/A |
#5 | N/A | 5 | -17% | N/A |